Differential allelic expression of PrP mRNA in carriers of the E200K mutation.
Creutzfeldt-Jakob disease (CJD) linked to the E200K mutation of the prion protein (PrP) gene presents with a wide range of age at disease onset. Since most patients are heterozygous for the mutation, we tested whether differential expression of mutant versus wild-type (wt) PrP may affect the age at disease onset in carriers of the mutation. We measured wt and mutant PrP protein and mRNA in Epstein-Barr virus (EBV)-transformed B cells of either E200K CJD patients or healthy E200K carriers. Our results suggests that while in most healthy carriers the expression of wt PrP was higher than that of E200K PrP, most of the E200K CJD patients express equal levels of both PrP proteins. Similar results were obtained for either PrP protein or PrP mRNA. These results suggest that preferential expression of PrP from the wt allele may modulate the outbreak of the disease in carriers of prion mutations. This notion is consistent with the results obtained in transgenic mice carrying a human PrP gene, which suggest that endogenous PrP protects mice from contracting scrapie after inoculation with human CJD brain. Similar mechanisms may prevail in other inherited diseases with variable phenotypes.
Rosenmann
H
H
Department of Neurology, Hadassah University Hospital, Jerusalem, Israel.
Halimi
M
M
Kahana
I
I
Biran
I
I
Gabizon
R
R
D000483:Alleles; D000818:Animals; D007562:Creutzfeldt-Jakob Syndrome / Q000235:genetics*; D015870:Gene Expression; D006579:Heterozygote; D006801:Humans; D015151:Immunoblotting; D007585:Jews / Q000235:genetics; D008002:Libya; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D015345:Oligonucleotide Probes; D010375:Pedigree; D011328:Prions / Q000235:genetics*; D012333:RNA, Messenger / Q000378:metabolism
D015345:Oligonucleotide Probes; D011328:Prions; D012333:RNA, Messenger